Uzbek Scientists Planned Ibn Sina Expedition
The research initiative aims to document the historical influence of Ibn Sina on medical science and pharmacology.
Updated on Sept. 26, 2026 in Botany
Live Poll
Do you believe international collaboration is necessary to effectively preserve the heritage of historical scientific figures?
Officials from the Center for Pharmaceutical Product Safety and the Ibn Sino Public Foundation met to coordinate efforts to promote Ibn Sina's scientific legacy. The collaboration includes plans for an upcoming expedition to India to analyze original manuscripts.
Why it matters
The initiative seeks to advance global recognition of Ibn Sina's contributions to early medicine and pharmacology through systematic study. By digitizing and analyzing primary source material, researchers aim to solidify his historical role in world science.
The proposed effort involves organizing joint scientific and practical events alongside Indian experts. The scope of work focuses on the documentation of Ibn Sina's pharmacological contributions compared to current archival records.
The players
Alisher Temirov
Director of the Center for Pharmaceutical Product Safety in Uzbekistan.
Nozimkhon Makhmudov
Chairman of the Board of the Ibn Sino Public Foundation.
The details
The project aims to synthesize existing pharmaceutical records with primary source materials attributed to Ibn Sina, also known as Avicenna. Researchers intend to use this data to develop a national brand that highlights his pharmacological methodology and historical impact on medical practice. The process requires collaborative verification of historical texts held in international collections.
Timeline
November 2026: Uzbek scientists are scheduled to conduct their scientific expedition to India.
The Tech Race
This project aligns with the Ibn Sino Public Foundation's broader mandate to preserve and promote historical medical manuscripts. It represents a shift from theoretical study to active international collaboration aimed at validating the historical contributions of Ibn Sina.
This initiative will likely result in the publication of new academic findings regarding early pharmacological practices. Researchers and historians can expect the project to establish a clearer record of Ibn Sina's contributions to global medical literature.
The takeaway
The project demonstrates a growing commitment to the empirical verification of historical scientific heritage. Observers should track updates on the November 2026 expedition to see which specific manuscripts are selected for the study.
What happens next
The planned scientific expedition to India is set for November 2026.
Further reading
Learn more about historical research and plant-based pharmacological origins in Botany.
Source note: This article includes information reported by Ўзбекистон Миллий ахборот агентлиги.
Live Poll
Do you believe international collaboration is necessary to effectively preserve the heritage of historical scientific figures?
